BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31117966)

  • 41. Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis.
    Shi Y; Zhu Y; Fan S; Liu X; Liang Y; Shan Y
    BMC Infect Dis; 2020 Apr; 20(1):287. PubMed ID: 32393342
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence and species distribution of microorganisms isolated among non-pregnant women affected by vulvovaginal candidiasis: A retrospective study over a 20 year-period.
    Intra J; Sala MR; Brambilla P; Carcione D; Leoni V
    J Mycol Med; 2022 Aug; 32(3):101278. PubMed ID: 35523109
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis.
    Fan SR; Liu XP
    Mycoses; 2011 Nov; 54(6):501-5. PubMed ID: 20406393
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India.
    Lattif AA; Mukhopadhyay G; Banerjee U; Goswami R; Prasad R
    J Microbiol Immunol Infect; 2011 Jun; 44(3):166-71. PubMed ID: 21524609
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation between antifungal resistance and virulence factors in Candida albicans recovered from vaginal specimens.
    El-Houssaini HH; Elnabawy OM; Nasser HA; Elkhatib WF
    Microb Pathog; 2019 Mar; 128():13-19. PubMed ID: 30562603
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal
    Mohammadi F; Hemmat N; Bajalan Z; Javadi A
    Biomed Res Int; 2021; 2021():5598907. PubMed ID: 34136569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distribution, antifungal susceptibility pattern and intra-Candida albicans species complex prevalence of Candida africana: A systematic review and meta-analysis.
    Gharehbolagh SA; Fallah B; Izadi A; Ardestani ZS; Malekifar P; M Borman A; Mahmoudi S
    PLoS One; 2020; 15(8):e0237046. PubMed ID: 32817677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biofilms Formed by Isolates from Recurrent Vulvovaginal Candidiasis Patients Are Heterogeneous and Insensitive to Fluconazole.
    Sherry L; Kean R; McKloud E; O'Donnell LE; Metcalfe R; Jones BL; Ramage G
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696240
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A New Phenotype in
    Sala A; Ardizzoni A; Spaggiari L; Vaidya N; van der Schaaf J; Rizzato C; Cermelli C; Mogavero S; Krüger T; Himmel M; Kniemeyer O; Brakhage AA; King BL; Lupetti A; Comar M; de Seta F; Tavanti A; Blasi E; Wheeler RT; Pericolini E
    mBio; 2023 Apr; 14(2):e0010723. PubMed ID: 36856418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phytolectin nanoconjugates in combination with standard antifungals curb multi-species biofilms and virulence of vulvovaginal candidiasis (VVC) causing Candida albicans and non-albicans Candida.
    Senthilganesh J; Kuppusamy S; Durairajan R; Subramaniyan SB; Veerappan A; Paramasivam N
    Med Mycol; 2022 Jan; 60(2):. PubMed ID: 34958385
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: Species distribution, antifungal susceptibility and virulence attributes.
    Ziccardi M; Souza LO; Gandra RM; Galdino AC; Baptista AR; Nunes AP; Ribeiro MA; Branquinha MH; Santos AL
    Int J Med Microbiol; 2015 Dec; 305(8):848-59. PubMed ID: 26319940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Species Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China.
    Wang FJ; Zhang D; Liu ZH; Wu WX; Bai HH; Dong HY
    Chin Med J (Engl); 2016 May; 129(10):1161-5. PubMed ID: 27174323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis.
    Boikov DA; Locke JB; James KD; Bartizal K; Sobel JD
    J Antimicrob Chemother; 2017 May; 72(5):1355-1358. PubMed ID: 28158577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiology, antifungal susceptibility, and pathogenicity of Candida africana isolates from the United Kingdom.
    Borman AM; Szekely A; Linton CJ; Palmer MD; Brown P; Johnson EM
    J Clin Microbiol; 2013 Mar; 51(3):967-72. PubMed ID: 23303503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment.
    Woodburn KW; Clemens LE; Jaynes J; Joubert LM; Botha A; Nazik H; Stevens DA
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Species and antifungal susceptibility profile of agents causing vulvovaginal candidiasis in a military population: a cross-sectional study.
    Trajano DTM; Melhem MSC; Takahashi JPF; Bonfietti LX; de Araújo MR; Corrêa VB; Araújo KBO; Barnabé V; Fernandes CG
    Med Mycol; 2023 Mar; 61(3):. PubMed ID: 36893795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antifungal Susceptibility Profile of Candida Albicans Isolated from Vulvovaginal Candidiasis in Xinjiang Province of China.
    Yan L; Wang XD; Seyedmousavi S; Yuan JN; Abulize P; Pan WH; Yu N; Yang YL; Hu HQ; Liao WQ; Deng SW
    Mycopathologia; 2019 Jun; 184(3):413-422. PubMed ID: 30968320
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low prevalence of antifungal resistant
    Farahyar S; Izadi S; Razmjou E; Falahati M; Roudbary M; Ashrafi-Khozani M; Ansari S; Fattahi A; Ghahri-Mobaser Z; Rahimi M
    Heliyon; 2020 Mar; 6(3):e03619. PubMed ID: 32215332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India.
    Sharma C; Wankhede S; Muralidhar S; Prakash A; Singh PK; Kathuria S; Kumar DA; Khan N; Randhawa HS; Meis JF; Chowdhary A
    Diagn Microbiol Infect Dis; 2013 May; 76(1):46-50. PubMed ID: 23537782
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil.
    Ramos LS; Figueiredo-Carvalho MH; Barbedo LS; Ziccardi M; Chaves AL; Zancopé-Oliveira RM; Pinto MR; Sgarbi DB; Dornelas-Ribeiro M; Branquinha MH; Santos AL
    J Antimicrob Chemother; 2015 Jan; 70(1):111-5. PubMed ID: 25134720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.